Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( August )
Competency-based interviewing: Selling your skillset
Drawing on your previous triumphs and failures can help you prove you're up to the job. But preparation is the key to success.(more)
Welcome to the real world
Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement
The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
PharmafocusNews Register for New Alert
News for October 2005
Previous Months: July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Marketing a high priority - but budgets still a battle
CIM survey shows central importance of marketing..(more)

 Oxford BioMedica's lung cancer candidate shows promise
Oxford company looking for big pharma partner..(more)

 Can the NHS become a world-class healthcare system?
Take part in the Pharmafocus & InPharm Career Survey 2006..(more)

 Pharma continues to invest in UK research and development
UK's home-grown pharma companies lead the way..(more)

 Once a day pill promises period-free contraception
Lybrel could launch in the US in the middle of 2006..(more)

 Resolute wins PR Consultancy of the Year award
PR agency working on global programme for Pfizer..(more)

 Vaccine companies to compete for UK pandemic contract
UK builds up Tamiflu stockpile ..(more)

 New approvals in TNF-blocker class
Wyeth and Amgen's Enbrel leads TNF-blocker class..(more)

 Tarceva/Avastin combination disappoints in kidney cancer
Rare setback for Californian biotech Genentech..(more)

 Merck to co-develop novel prostate cancer candidate
Merck signs deal with Californian cancer biotech company..(more)

 Exubera recommended by European regulator
Exubera receives positive opinion from CHMP..(more)

 Pfizer wins UK Lipitor court battle
Ranbaxy to challenge Lipitor patent in US..(more)

 Pharma increases vaccine production as bird flu hits Europe
President Bush urges pharma companies to up production..(more)

 VNU shareholders rebel over IMS bid
Questions arise over consumer group's move into pharma..(more)

 Merck looks to rebuild reputation one year on from Vioxx
US corporate marketing campaign spreads to Europe..(more)

 Unions vote against NHS 'privatisation'
Unison critical of expanding private sector's role in NHS..(more)

 EMEA reforms to speed drug approval
Scientific advice process to be made quicker and more consistent..(more)

 Creative Lynx to work on Novartis transplantation brands
Agency to provide full range of creative work..(more)

 GPs need pharma expertise
GPs not prepared for change to PBC..(more)

 Sanofi-Aventis launch new short-acting insulin competitor Apidra
Apidra will complement the company's market-leading Lantus..(more)

 Astellas launches Flomaxtra XL
Astellas looks to maintain sales after patent expiry..(more)

 NICE seeks urgent fix for slow appraisals
Delayed cancer drug appraisals particularly contentious..(more)

 Genzyme opens first European research centre in Cambridge
Genzyme injecting over $500 million into infrastructure ..(more)

 Resolute selected for IBD campaign
Procter & Gamble chooses Resolute Communications..(more)

 Pharma cast as 'bad guys' in Hollywood blockbuster
ABPI philosophical about the industry's portrayal..(more)

 Davis to leave Takeda UK
Davis seeks new challenge at consumer company..(more)

 New leader for FDA in turmoil
Mixed feelings over FDA commissioner's resignation ..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.